5 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
1 Jun 23
Current report (foreign)
4:24pm
and submucosal colon that has a globally increasing prevalence thought to be driven by societal changes. There are approximately 600,000 to 900,000 people
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
of the mucosal and submucosal colon that has a globally increasing prevalence thought to be driven by societal changes. There are approximately 600,000
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
or influence our operations as the government deems appropriate to further regulatory, political and societal goals. The PRC government has recently published
- Prev
- 1
- Next